Cargando…

A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer

As the second most common cause of death amongst men in the United States, prostate cancer is a type of cancer that is known to develop and originate in the prostate gland. The main function of the prostate gland is to produce seminal fluid in which the sperm bathes. The seminal fluids are necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaler, Jasndeep, Hussain, Azhar, Haque, Ayema, Naveed, Hassan, Patel, Sundip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681941/
https://www.ncbi.nlm.nih.gov/pubmed/33240734
http://dx.doi.org/10.7759/cureus.11617
_version_ 1783612612878008320
author Kaler, Jasndeep
Hussain, Azhar
Haque, Ayema
Naveed, Hassan
Patel, Sundip
author_facet Kaler, Jasndeep
Hussain, Azhar
Haque, Ayema
Naveed, Hassan
Patel, Sundip
author_sort Kaler, Jasndeep
collection PubMed
description As the second most common cause of death amongst men in the United States, prostate cancer is a type of cancer that is known to develop and originate in the prostate gland. The main function of the prostate gland is to produce seminal fluid in which the sperm bathes. The seminal fluids are necessary for allowing the sperm to move easily through the urethra and also allows successful fertilization by providing an alkaline environment for the sperm in the acidic nature of the vagina. The seminal vesicles are two smaller glands that are attached to either side of the prostate gland and in radical prostatectomies, can get removed. In the event that the seminal vesicles are removed during a radical prostatectomy, the individual is unable to produce any seminal fluids and thus, becoming infertile. Prostate cancer is most commonly seen in patients over the age of 66 years, however, in the presence of predisposing risk factors, may occur as early as in the late 40s. Certain risk factors may speed the presentation of prostate cancer in individuals and thus, mandatory screening is recommended around the age of 45. If no risk factors are present, screening is recommended to begin after the age of 50 years. Screening for prostate cancer is focused on looking for prostate-specific antigen (PSA) in a blood test, though this may not be the most reliable method. The method of diagnosis stems from further testing done following an abnormal PSA test. A digital rectal examination and ultrasonography may also be used to assist with the diagnosis of prostate cancer. Though there are several different types of pharmaceutical interventions currently present in the eradication of prostate cancer, with androgen deprivation therapy being the most commonly used, surgical interventions may be utilized to completely resect cancer from an individual. Different radical prostatectomies are used; the appropriate approach utilized is dependent on the extensiveness of cancer and the type of cancer that is present.
format Online
Article
Text
id pubmed-7681941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76819412020-11-24 A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer Kaler, Jasndeep Hussain, Azhar Haque, Ayema Naveed, Hassan Patel, Sundip Cureus Radiation Oncology As the second most common cause of death amongst men in the United States, prostate cancer is a type of cancer that is known to develop and originate in the prostate gland. The main function of the prostate gland is to produce seminal fluid in which the sperm bathes. The seminal fluids are necessary for allowing the sperm to move easily through the urethra and also allows successful fertilization by providing an alkaline environment for the sperm in the acidic nature of the vagina. The seminal vesicles are two smaller glands that are attached to either side of the prostate gland and in radical prostatectomies, can get removed. In the event that the seminal vesicles are removed during a radical prostatectomy, the individual is unable to produce any seminal fluids and thus, becoming infertile. Prostate cancer is most commonly seen in patients over the age of 66 years, however, in the presence of predisposing risk factors, may occur as early as in the late 40s. Certain risk factors may speed the presentation of prostate cancer in individuals and thus, mandatory screening is recommended around the age of 45. If no risk factors are present, screening is recommended to begin after the age of 50 years. Screening for prostate cancer is focused on looking for prostate-specific antigen (PSA) in a blood test, though this may not be the most reliable method. The method of diagnosis stems from further testing done following an abnormal PSA test. A digital rectal examination and ultrasonography may also be used to assist with the diagnosis of prostate cancer. Though there are several different types of pharmaceutical interventions currently present in the eradication of prostate cancer, with androgen deprivation therapy being the most commonly used, surgical interventions may be utilized to completely resect cancer from an individual. Different radical prostatectomies are used; the appropriate approach utilized is dependent on the extensiveness of cancer and the type of cancer that is present. Cureus 2020-11-22 /pmc/articles/PMC7681941/ /pubmed/33240734 http://dx.doi.org/10.7759/cureus.11617 Text en Copyright © 2020, Kaler et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Kaler, Jasndeep
Hussain, Azhar
Haque, Ayema
Naveed, Hassan
Patel, Sundip
A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title_full A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title_fullStr A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title_full_unstemmed A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title_short A Comprehensive Review of Pharmaceutical and Surgical Interventions of Prostate Cancer
title_sort comprehensive review of pharmaceutical and surgical interventions of prostate cancer
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681941/
https://www.ncbi.nlm.nih.gov/pubmed/33240734
http://dx.doi.org/10.7759/cureus.11617
work_keys_str_mv AT kalerjasndeep acomprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT hussainazhar acomprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT haqueayema acomprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT naveedhassan acomprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT patelsundip acomprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT kalerjasndeep comprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT hussainazhar comprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT haqueayema comprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT naveedhassan comprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer
AT patelsundip comprehensivereviewofpharmaceuticalandsurgicalinterventionsofprostatecancer